A phase I clinical trial on the use of autograft mesenchymal stem cells for treatment of diabetic chronic kidney disease
Phase 1
- Conditions
- Diabetic Nephropathy.Diabetic nephropathy
- Registration Number
- IRCT138804091267N19
- Lead Sponsor
- rology and Nephrology Research Center ( UNRC), Shahid Beheshti University, M.C.( SBMU), Tehran, I.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Presence of stage III diabetic nephropathy (GFR between 30 to 60 ml / min /1.73 m2), controlled hypertension, Blood creatinine level less than 2 mg/dl
Exclusion criteria: History or presence of psychological disorders, history or presence of previous immune deficiencies, consumption of immunosuppressive drugs, presence of renal artery stenosis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Kidney function. Timepoint: one year after injection. Method of measurement: Bun, Cr.
- Secondary Outcome Measures
Name Time Method Complication. Timepoint: to one year. Method of measurement: Billirubin.